Medifast
MED
216 hedge funds and large institutions have $717M invested in Medifast in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 75 increasing their positions, 73 reducing their positions, and 39 closing their positions.
10.27% more ownership
Funds ownership: 87.19% → 97.46% (+10%)
3% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 73
1% less capital invested
Capital invested by funds: $724M → $717M (-$6.96M)
3% less funds holding
Funds holding: 223 → 216 (-7)
15% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 39
47% less call options, than puts
Call options by funds: $10.7M | Put options by funds: $20.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$22.1M |
| 2 |
Man Group
London,
United Kingdom
|
+$15.2M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$14.1M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$11.1M |
| 5 |
BlackRock
New York
|
+$8.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$7.88M |
| 2 |
JP Morgan Chase
New York
|
-$5.63M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.99M |
| 4 |
SSCM
Summit Street Capital Management
New York
|
-$2.07M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.05M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DCM
251
Davidson Capital Management
Corpus Christi,
Texas
| – | -$4.64K | -62 | Closed |
|
|
LFA
252
LGT Financial Advisors
Dallas,
Texas
| – | -$2.17K | -29 | Closed |
|
|
UB
253
UMB Bank
Kansas City,
Missouri
| – | -$1.35K | -18 | Closed |
|
254
Bessemer Group
Woodbridge,
New Jersey
| – | -$1K | -15 | Closed |
|
|
BAAM
255
Baker Avenue Asset Management
San Francisco,
California
| – | -$674 | -9 | Closed |
|
MED Hedge Fund Activity: Q4 2023 in Review
216 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2023, worth a combined $717M — down 0.96% from $724M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of MED and 33 opened new positions — a net loss of 6 holders — while 73 trimmed existing stakes and 75 added.
The largest buyer was Morgan Stanley, adding an estimated $22.1M. The largest seller was Millennium Management, cutting an estimated $7.88M.
- 216 institutional investors held Medifast (MED) as of Q4 2023, down from 223 in Q3 2023.
- Funds reported $717M of Medifast stock for Q4 2023, down 0.96% quarter-over-quarter.
- 33 funds opened new Medifast positions in Q4 2023 and 39 closed out, a net change of -6 holders.
- The largest Medifast buyer in Q4 2023 was Morgan Stanley, an estimated $22.1M added.
- The largest Medifast seller in Q4 2023 was Millennium Management, an estimated $7.88M sold.
Based on aggregated 13F filings for Q4 2023.